Gain Therapeutics Inc’s recently made public that its Director Riley Jeffrey Scott acquired Company’s shares for reported $0.12 million on Mar 28 ’24. In the deal valued at $3.86 per share,30,000 shares were bought. As a result of this transaction, Riley Jeffrey Scott now holds 30,000 shares worth roughly $38400.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Alder Matthias sold 206 shares, generating $507 in total proceeds. Upon selling the shares at $2.46, the Chief Executive Officer now owns 5,286 shares.
Before that, Alder Matthias sold 1,820 shares. Gain Therapeutics Inc shares valued at $4,550 were divested by the Chief Executive Officer at a price of $2.50 per share. As a result of the transaction, Alder Matthias now holds 4,855 shares, worth roughly $6214.400000000001.
Oppenheimer initiated its Gain Therapeutics Inc [GANX] rating to an Outperform in a research note published on April 12, 2021; the price target was $30. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in mid April with a ‘”a Buy”‘ rating.
Price Performance Review of GANX
On Friday, Gain Therapeutics Inc [NASDAQ:GANX] saw its stock jump 2.40% to $1.28. Over the last five days, the stock has lost -0.78%. Gain Therapeutics Inc shares have fallen nearly -60.80% since the year began. Nevertheless, the stocks have fallen -71.49% over the past one year. While a 52-week high of $5.33 was reached on 02/07/24, a 52-week low of $1.20 was recorded on 06/28/24. SMA at 50 days reached $2.3722, while 200 days put it at $3.1776. A total of 0.55 million shares were traded, compared to the trading of 0.33 million shares in the previous session.
Levels Of Support And Resistance For GANX Stock
The 24-hour chart illustrates a support level at 1.2133, which if violated will result in even more drops to 1.1467. On the upside, there is a resistance level at 1.3333. A further resistance level may holdings at 1.3867. The Relative Strength Index (RSI) on the 14-day chart is 26.82, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.2576, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.16%. Stochastics%K at 4.87% indicates the stock is a buying.
